Literature DB >> 19209827

Caldesmon and the regulation of cytoskeletal functions.

C L Albert Wang1.   

Abstract

Caldesmon (CaD) is an extraordinary actin-binding protein, because in addition to actin, it also bindsmyosin, calmodulin and tropomyosin. As a component of the smoothmuscle and nonmuscle contractile apparatus CaD inhibits the actomyosin ATPase activity and its inhibitory action is modulated by both Ca2+ and phosphorylation. The multiplicity of binding partners and diverse biochemical properties suggest CaD is a potent and versatile regulatory protein both in contractility and cell motility. However, after decades ofinvestigation in numerous laboratories, hard evidence is still lacking to unequivocally identify its in vivo functions, although indirect evidence is mounting to support an important role in connection with the actin cytoskeleton. This chapter reviews the highlights of the past findings and summarizes the current views on this protein, with emphasis of its interaction with tropomyosin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19209827      PMCID: PMC2975104          DOI: 10.1007/978-0-387-85766-4_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  196 in total

1.  Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs.

Authors:  I A Yamboliev; W T Gerthoffer
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

2.  Mutant Caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis.

Authors:  S Yamashiro; H Chern; Y Yamakita; F Matsumura
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

3.  The effects of phosphorylation of smooth-muscle caldesmon.

Authors:  P K Ngai; M P Walsh
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

4.  Effect of caldesmon on the ATPase activity and the binding of smooth and skeletal myosin subfragments to actin.

Authors:  M E Hemric; J M Chalovich
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

5.  Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells.

Authors:  N Ueki; K Sobue; K Kanda; T Hada; K Higashino
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.

Authors:  V Shah; S Bharadwaj; K Kaibuchi; G L Prasad
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

7.  Caldesmon exhibits a clustered distribution along individual chicken gizzard native thin filaments.

Authors:  K Mabuchi; Y Li; A Carlos; C L Wang; P Graceffa
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

8.  The major myosin-binding site of caldesmon resides near its N-terminal extreme.

Authors:  Y Li; S Zhuang; H Guo; K Mabuchi; R C Lu; C A Wang
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

9.  Caldesmon reduces the apparent rate of binding of myosin S1 to actin-tropomyosin.

Authors:  A Sen; Y D Chen; B Yan; J M Chalovich
Journal:  Biochemistry       Date:  2001-05-15       Impact factor: 3.162

10.  The dissociation of 1-N6-ethenoadenosine diphosphate from regulated actomyosin subfragment 1.

Authors:  S S Rosenfeld; E W Taylor
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

View more
  19 in total

1.  Acrylodan-labeled smooth muscle tropomyosin reports differences in the effects of troponin and caldesmon in the transition from the active state to the inactive state.

Authors:  Joseph M Chalovich; Evan Lutz; Tamatha Baxley; Mechthild M Schroeter
Journal:  Biochemistry       Date:  2011-06-14       Impact factor: 3.162

2.  Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.

Authors:  Danielle M Trappanese; Sarah Sivilich; Hillevi K Ets; Farah Kako; Michael V Autieri; Robert S Moreland
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

3.  TSH stimulates the proliferation of vascular smooth muscle cells.

Authors:  Limin Tian; Jing Ni; Tiankang Guo; Jing Liu; Yamei Dang; Qian Guo; Luyan Zhang
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

4.  Histochemical localization of caldesmon in the CNS and ganglia of the mouse.

Authors:  Christoph N Köhler
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

Review 5.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  Desmoplastic infantile ganglioglioma with late presentation. A clinical, radiological and histopathological analysis.

Authors:  Alfredo E Romero-Rojas; Julio A Diaz-Perez; Alfonso Lozano-Castillo
Journal:  Neuroradiol J       Date:  2013-12-18

7.  Forkhead box O member FOXO1 regulates the majority of follicle-stimulating hormone responsive genes in ovarian granulosa cells.

Authors:  Maria K Herndon; Nathan C Law; Elyse M Donaubauer; Brandon Kyriss; Mary Hunzicker-Dunn
Journal:  Mol Cell Endocrinol       Date:  2016-06-17       Impact factor: 4.102

Review 8.  Comparative biomechanics of thick filaments and thin filaments with functional consequences for muscle contraction.

Authors:  Mark S Miller; Bertrand C W Tanner; Lori R Nyland; Jim O Vigoreaux
Journal:  J Biomed Biotechnol       Date:  2010-06-06

9.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

10.  Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.

Authors:  Ying-Ming Liou; Chu-Lung Chan; Renjian Huang; Chih-Lueh A Wang
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.